The New Era of Total Neoadjuvant FLOT Therapy for Locally Advanced, Resectable Gastric Cancer: A Propensity-Matched Comparison With Standard Perioperative Therapy.

J Surg Oncol · 2025 · PMC12044282 · PMID 39400342

Europe PMC DOI

hedged sentence

0.2500

closest p · 5.0× alpha

0.2500

boldest claim

The sentences

did not reach statistical significancep = 0.25not close (p > 0.1)

Analysis of the CAP score revealed a trend toward a higher complete response rate in the FLOT x8 group (18.9%) compared to the FLOT 4+4 group (8.1%), though this did not reach statistical significance ( p = 0.25).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.